BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:32 PM
 | 
Mar 22, 2007
 |  BC Extra  |  Company News

FDA accepts Pozen's Trexima response

FDA accepted POZN's amended response to a June approvable letter for Trexima sumatriptan/naproxen to treat acute migraine. FDA told the company that it...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >